Rankings
▼
Calendar
RLAY Q4 2023 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
-$1,000
-100.4% YoY
Gross Profit
-$1,000
100.0% margin
Operating Income
-$92M
9219600.0% margin
Net Income
-$83M
8349500.0% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$89M
Free Cash Flow
-$89M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$844M
Total Liabilities
$92M
Stockholders' Equity
$752M
Cash & Equivalents
$144M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$1,000
$253,000
-100.4%
Gross Profit
-$1,000
-$64M
+100.0%
Operating Income
-$92M
-$73M
-26.6%
Net Income
-$83M
-$68M
-23.7%
← FY 2023
All Quarters
Q1 2024 →